Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center (Q38320548)

2 September 2017

title

Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center (English)

1 reference

2 September 2017

1 reference

10

Yoshihiko Maehara

1 reference

2 September 2017

Sung Kwan Bae

1

1 reference

2 September 2017

Shinji Shimoda

2

1 reference

2 September 2017

Toru Ikegami

3

1 reference

2 September 2017

Tomoharu Yoshizumi

4

1 reference

2 September 2017

Norifumi Harimoto

5

1 reference

2 September 2017

Shinji Itoh

6

1 reference

2 September 2017

Yuji Soejima

7

1 reference

2 September 2017

Hideaki Uchiyama

8

1 reference

2 September 2017

Ken Shirabe

9

1 reference

2 September 2017

publication date

15 January 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

45

1 reference

2 September 2017

issue

12

1 reference

2 September 2017

page(s)

1203-1210

1 reference

Liver transplantation (2).

2 September 2017

cites work

1 reference

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis

21 January 2018

1 reference

Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective

21 January 2018

1 reference

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

21 January 2018

1 reference

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence

21 January 2018

1 reference

Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation

21 January 2018

1 reference

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

21 January 2018

1 reference

Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

21 January 2018

1 reference

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation

21 January 2018

1 reference

High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence

21 January 2018

1 reference

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

21 January 2018

1 reference

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

21 January 2018

1 reference

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation

21 January 2018

1 reference

Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin

21 January 2018

1 reference

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation

21 January 2018

1 reference

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

21 January 2018

1 reference

Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEPR.12489

1 reference

2 September 2017

1 reference